Prestige Wealth Management Group LLC
Position in STOK — Stoke Therapeutics, Inc.
CIK 1772715
FLEMINGTON, NJ
Position in STOK
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$6,512
+$164 QoQ
Shares Held
200
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in STOK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Prestige Wealth Management Group LLC holds $563,805 across 26 Biotechnology names. STOK ranks #7 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
847 | $378,218 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
226 | $74,776 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
63 | $48,676 | |
| 4 | INCY |
Incyte Corp
|
132 | $12,423 | |
| 5 | MRNA |
Moderna, Inc.
|
137 | $6,959 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
107 | $6,708 | |
| 7 | STOK |
Stoke Therapeutics, Inc.
This page
|
200 | $6,512 | |
| 8 | ARQT |
Arcutis Biotherapeutics, Inc.
|
250 | $5,890 |
All Filings in STOK
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,512 | 200 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $6,348 | 200 | Shares | Sole | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||